When: Binary resolution event

Then: Reassess full thesis

HOLD core position, reduce modest exposure via options rather than spot sales, reassess if AMAT breaks $402.89 on heavy volume with expanding histogram

• Working capital deterioration (AR up 28% QoQ, revenue up 12.8%) reflects billing acceleration during new fab bookings and EPIC Center commitment, not structural breakdown; cash typically arrives 60-90 days later
• FCF dropped 90% QoQ due to capex surge from $510 million to $635 million and guided $2.5 billion annualized EPIC Center buildout; underlying cash generation remains strong at $7.96 billion operating cash flow in fiscal 2025 and $8.7 billion in fiscal 2024
• AMAT's 14% monthly drop reflects mean reversion after 72.5% YTD run from $154 to $740, not idiosyncratic fundamental breakdown; stocks with biggest gains see biggest profit-taking hits mechanically
• Forward PE of 23.76x with 60% EPS growth yields PEG of 0.88, indicating growth is priced at a discount; fortress balance sheet with $8.24 billion cash, $7.27 billion debt, $154 million net debt, current ratio of 2.42 provides hard floor
• Selling into hypothetical $472-$501 rebound zone requires strength to materialize; current tape shows two consecutive closes below $450 with high at $443.50, making that rebound hypothetical not real
• Position sizing math flawed: holding full size through 20% drop costs 60-70 bps while trimming costs 20-40 bps, but ignores symmetric-gain counterfactual where $105 recovery at $543 represents 30% of position value on $348 billion market cap book

→ vs aggressive: AR up 28% QoQ versus revenue up 12.8% framed as red flag, but this reflects order-to-collection lag during record fab bookings and EPIC Center commitment, not broken business; same analysts will call it 'billing acceleration' when cash lands in Q3

→ vs aggressive: FCF collapse framing is selective; ignores capex surge to $635 million from $510 million and explicit $2.5 billion annualized guidance; treating strategic investment as deterioration causes selling before inflection

→ vs aggressive: 'Idiosyncratic selling' argument is analytically dishonest; AMAT's 14% drop is mechanical mean reversion after 72.5% YTD outperformance, not evidence of fundamental breakdown; cannot use relative price action for directional call without acknowledging prior relative strength

→ vs aggressive: Position sizing math flawed; asymmetric-loss argument ignores symmetric-gain counterfactual; selling into $472-$501 zone locks in 7% loss if bounce succeeds, worse loss if it fails, and worst outcome if stock gaps up on Fed pivot

→ vs aggressive: No margin of safety claim ignores PEG of 0.88 and fortress balance sheet; this is not a 2008-style meltdown but high-quality compounder through temporary working capital trough during strategic investment in hostile macro

→ vs aggressive: Framing waiting for confirmation above $544 as 'giving back 20-25%' assumes AMAT goes to $350; ignores scenario where yields reverse on benign CPI print and AMAT goes to $480 next week

Trim 25-35% of position in tranches over 1-2 weeks, reduce benchmark weight from 3-3.5% toward 2-2.5%, hold core position with $402.89 technical invalidation as exit trigger, layer in defined re-entry framework rather than spot hedges

• Trim 25-35% now in tranches over 1-2 weeks rather than waiting for $472-$501 bounce zone that tape doesn't support
• Reduce from 3-3.5% benchmark weight to approximately 2-2.5%
• Keep core position: 200-day structural support at $402.89 intact, AMAT 8.8% above that level
• Exit remainder on daily close below $402.89 with expanding volume and deteriorating MACD histogram
• First re-entry trigger: sustained close above $543 with MACD histogram turning less negative and RSI recovering through 50
• Second re-entry trigger: flush into $400-$410 zone producing daily reversal candle with volume confirmation
• Working capital/AR concerns are a 'yellow flag' warranting sizing discipline, not full exit
• Put-spread hedges are expensive given elevated implied vol; prefer defined technical invalidation over decaying spot hedges
• Conservative analyst's billing acceleration reframing is plausible but doesn't eliminate real cash-not-yet-collected risk in hostile macro environment (10-year at 4.79%, 89% probability of no Fed cuts in 2026)
• Expected value framework across all paths, not just bear case, is the correct lens

→ vs aggressive: The $472-$501 trim zone assumes countertrend bounce the tape isn't currently offering; most recent session printed open equal to high at $443.50 and closed near the low—every bounce is being sold. May wait three weeks and watch stock drift to $410 first.

→ vs aggressive: Asymmetric-loss framing is one-sided; if AMAT reverses on benign CPI or Fed dovish surprise and captures only half the move, that's a real economic cost not being priced. Should use expected value across all paths, not just the path supporting the trade.

→ vs conservative: Working capital deterioration reframed as billing acceleration is plausible but still represents real cash not yet collected; in hostile macro with 10-year at 4.79% and 89% probability of no cuts in 2026, don't hold names with even slightly ambiguous cash conversion.

→ vs conservative: Put-spread hedge idea glosses over real cost; with implied vol elevated and options markets pricing wide one-year range, premium drag over a quarter or two is a real return hit, not a free lunch.